000 01151 a2200337 4500
005 20250517174516.0
264 0 _c20180423
008 201804s 0 0 eng d
022 _a2213-8595
024 7 _a10.1016/S2213-8587(17)30288-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBone, Henry G
245 0 0 _aDenosumab treatment in postmenopausal women with osteoporosis - Authors' reply.
_h[electronic resource]
260 _bThe lancet. Diabetes & endocrinology
_c10 2017
300 _a768-769 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aBone Density
650 0 4 _aBone Density Conservation Agents
650 0 4 _aDenosumab
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOsteoporosis
650 0 4 _aOsteoporosis, Postmenopausal
650 0 4 _aPostmenopause
700 1 _aWagman, Rachel B
700 1 _aPannacciulli, Nicola
700 1 _aPapapoulos, Socrates
773 0 _tThe lancet. Diabetes & endocrinology
_gvol. 5
_gno. 10
_gp. 768-769
856 4 0 _uhttps://doi.org/10.1016/S2213-8587(17)30288-7
_zAvailable from publisher's website
999 _c27593301
_d27593301